The global poultry and livestock industries face a persistent threat from Eimeria species, which trigger devastating outbreaks of coccidiosis. These parasitic infections lead to significant economic losses through reduced feed conversion, impaired growth, and increased mortality rates. Identifying a reliable China/Custom coccidia or eimeria/coccidiosis factory is no longer just about procurement; it is about finding a technical partner capable of delivering high-purity antigens and specialized pharmaceutical interventions.
Since 2008, Shijiazhuang Huajun Animal Pharmaceutical Co., Ltd. (ZTHJ Pharma) has bridged this gap by integrating advanced R&D with high-tech veterinary drug preparation. Operating out of a massive 21,000-square-meter facility in Xinle City, the company has evolved into a strategic hub for customized parasitic solutions. By leveraging a 2022 GMP-certified production environment, we provide the foundational science and manufacturing scale required to mitigate the complex lifecycle of coccidia across international borders.
Precision in parasitic control requires more than standard chemical mixing. As a premier China/Custom coccidia or eimeria/coccidiosis factory, our technical framework focuses on the development of specific antigens and peptides that target Eimeria at the cellular level. Our infrastructure supports over 100 product varieties, including powders, premixes, and oral solutions designed for maximum bioavailability in the avian intestinal tract.
| Performance Metric | Industry Significance | Our Engineering Standard | Advantage |
|---|---|---|---|
| Antigen Specificity | Determines the effectiveness against multiple Eimeria strains. | Custom Peptide & Specific Antigen R&D. | Higher cross-protection rates in diverse environments. |
| Manufacturing Rigor | Prevents cross-contamination and ensures dosage accuracy. | 2022 Ministry of Agriculture GMP Acceptance. | Global compliance for international trade safety. |
| Facility Scale | Dictates lead times and bulk supply stability. | 21,000 sqm dedicated production zone. | Consistent supply for large-scale livestock operations. |
| Formulation Variety | Allows for flexible delivery (Water vs. Feed). | Powder, Premix, and Liquid Oral Solutions. | Optimized ROI through tailored application methods. |
Maximizing the return on investment in animal health requires a shift from reactive treatment to proactive, data-driven prevention. Partnering with an established China/Custom coccidia or eimeria/coccidiosis factory allows distributors and large-scale farms to access "Value Engineering" in their pharmaceutical supply chain. By utilizing high-tech preparations such as Bacillus Coagulans SNZ 1969 and specialized peptides, we reduce the dependency on traditional antibiotics, thereby lowering the risk of drug resistance and improving the long-term health of the flock.
Our global footprint—supported by multi-language capabilities in Arabic, French, German, and Spanish—ensures that our technical expertise is accessible to the worldwide market. The following data visualization demonstrates the efficiency gains observed when transitioning from generic treatments to the precision-engineered solutions provided by our facility.
Related products
Top Selling Products
